Lorazepam and Ritalin la drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Ritalin la (methylphenidate hydrochloride). Common drug interactions include kidney enlargement among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Ritalin la. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Ritalin la?

Ritalin la has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 2,563 Ritalin la users. Check the latest studies of Ritalin la.



On Jul, 16, 2026

32 people who take Lorazepam and Ritalin la together, and have interactions are studied.

Lorazepam and Ritalin la drug interactions.

What are the common drug interactions of Lorazepam and Ritalin La, by gender? *:

female:

  1. Kidney enlargement
  2. Weight increased
  3. Urinary tract infection
  4. Abdominal pain upper
  5. Alcoholism (problems with alcohol)
  6. Bacterial infection
  7. Blood calcium increased
  8. Blood cholesterol increased
  9. Blood triglycerides increased
  10. Coeliac disease (simple food intolerance)

male:

  1. Abdominal pain upper
  2. Nervousness
  3. Memory impairment
  4. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  5. Sciatic nerve injury
  6. Therapeutic response decreased (less preventive response)
  7. Tooth extraction
  8. Tooth fracture
  9. Upper respiratory tract infection
  10. Urine output decreased

What are the common drug interactions of Lorazepam and Ritalin La, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Food poisoning (poison in food)
  2. Influenza
  3. Initial insomnia (feeling of inadequate or poor-quality sleep)
  4. Memory impairment
  5. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  6. Sciatic nerve injury
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Tooth fracture
  9. Upper respiratory tract infection
  10. Vomiting

30-39:

  1. Bacterial infection
  2. Erythema (redness of the skin)
  3. Eustachian tube patulous (benign condition in which the eustachian tube stays open most of the time)
  4. Fall
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Otorrhoea (discharge from the ear)
  8. Rib fracture
  9. Therapeutic response unexpected

40-49:

  1. Duodenal ulcer
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Hepatic enzyme increased
  4. Hepatic pain (pain in liver)
  5. Hepatic steatosis (fatty liver disease)
  6. Lymphoedema (localized fluid retention and tissue swelling)
  7. Type 2 diabetes mellitus
  8. Weight increased
  9. Alcoholism (problems with alcohol)
  10. Blood cholesterol increased

50-59:

n/a

60+:

  1. Abdominal pain upper
  2. Nervousness
  3. Suicidal ideation
  4. Constipation
  5. Decreased appetite
  6. Urine output decreased

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 53.12%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 25.00%
  3. Hereditary Angioedema (recurrent episodes of severe swelling): 4 people, 12.50%
  4. Bipolar Disorder (mood disorder): 3 people, 9.38%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.25%
  6. Rashes (redness): 2 people, 6.25%
  7. Nervousness: 2 people, 6.25%
  8. Insomnia (sleeplessness): 2 people, 6.25%
  9. High Blood Pressure: 2 people, 6.25%
  10. High Blood Cholesterol: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Ritalin la?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Ritalin la:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ritalin la:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ritalin la and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and methylphenidate hydrochloride (the active ingredients of Lorazepam and Ritalin la, respectively), and Lorazepam and Ritalin la (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: